Mouse Skin Disease
Mouse Skin Disease - Related Videos
08:01
Cutaneous Surgical Denervation: A Method for Testing the Requirement for Nerves in Mouse Models of Skin Disease
0 Views •
Cited by 9 •
2016
This article includes detailed protocols for genetic labeling of mouse skin, surgical denervation, skin biopsy and visualizing labeled epithelia by whole-mount β-galactosidase staining. These methods can be used to test the requirement for nerves in mouse models of normal and pathological skin.
01:23
Skin Diseases and Disorders
0 Views •
2023
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices. Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
03:35
A Technique for Human Skin Grafting in a Mouse Model
0 Views •
2025
This video demonstrates a method for grafting human skin onto an immunodeficient mouse with a suppressed neutrophil response. The method involves applying human split-thickness skin to the mouse's graft bed, sealing it, and covering it for recovery. Eventually, the human skin adheres to the mouse's skin, establishing vascularization and circulation, resulting in a successful skin xenograft.
10:51
Isolation and Culture of Primary Mouse Keratinocytes from Neonatal and Adult Mouse Skin
0 Views •
Cited by 88 •
2017
Epidermal keratinocytes form a functional skin barrier and are positioned at the front line of host defense against external environmental insults. Here we describe methods for isolation and primary culture of epidermal keratinocytes from neonatal and adult mouse skin, and induction of terminal differentiation and UVB-triggered inflammatory response from keratinocytes.
03:02
Chemical-induced Two-stage Skin Carcinogenesis Model: An Experimental In Vivo Mouse Model of Skin Cancer
0 Views •
2023
This video describes the procedure to induce two-stage skin carcinogenesis to study tumor initiation by topical application of chemicals. In the first step, a mutagen, DMBA, is applied onto the skin of a mouse model which initiates tumor formation by causing mutations in the stem cells, followed by the application of a growth stimulator, TPA, which accelerates skin papilloma formation.
FAQs
Immune-cell activation can drive inflammatory changes, whereas microbial infection introduces a disease process associated with the presence of infectious organisms. These mechanisms may affect skin structure and tissue responses differently, so researchers interpret them alongside clinical assessment and laboratory findings. Distinguishing the underlying route helps clarify disease cause and supports selection of an appropriate mouse model for medical research.
The epidermal barrier helps maintain the skin’s structural integrity, so altered barrier function can contribute to disease-related changes even when infection is not the primary cause. Examining this mechanism allows researchers to connect visible dermatologic abnormalities with changes in skin biology. It also helps separate disorders driven by barrier disruption from those associated mainly with immune activation, infection, or abnormal tissue growth.
Mutations may disrupt tissue growth and repair, creating a genetic basis for abnormal skin development or persistent disease-related changes. This mechanism differs from conditions initiated primarily by infection or immune-cell activation. Genetic analysis can therefore identify whether a mouse disorder reflects an inherited molecular disturbance and can strengthen interpretation of findings relevant to skin biology and human dermatology.
A reliable assessment combines clinical evaluation with histopathology, microbiological testing, and genetic analysis. Clinical assessment characterizes the observed disorder, while histopathology examines changes in tissue structure. Microbiological testing investigates infection, and genetic analysis evaluates mutation-related causes. Using these approaches together reduces reliance on a single finding and improves discrimination among inflammatory, infectious, genetic, and neoplastic conditions.
Each method addresses a different source of evidence. Histopathology reveals how disease has altered skin structure, microbiological testing assesses whether microbial infection contributes to the condition, and genetic analysis examines mutations that may disrupt growth or repair. Their complementary results help researchers connect tissue findings with disease mechanisms and characterize mouse models more precisely for medical studies.
These models are useful when researchers need to investigate causes of skin disorders, study changes in tissue structure, or examine immune responses in a controlled biological system. They can also support evaluation of potential therapies by linking disease mechanisms with measurable tissue and immune findings. Careful characterization is essential so that conclusions remain relevant to human dermatology.
Mouse studies provide a way to examine relationships among skin biology, immune responses, tissue growth, repair, infection, and disease-associated mutations. Researchers can compare these mechanistic findings with human dermatologic questions and use them to evaluate potential therapies. The relevance of such work depends on accurate disease classification through clinical, structural, microbiological, and genetic evidence.